AuditLine › HHS OIG › Food and Drug Administration
HHS OIG recommendation 13-E-04-029.06
FDA should seek legislative authority to enforce FDA assessment plans.
The recommendation, in the publisher's words
FDA should seek legislative authority to enforce FDA assessment plans.
- Responsible agency
- Food and Drug Administration
- Issued
- February 12, 2013
- Report
- FDA Lacks Comprehensive Data To Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety (OEI-04-11-00510) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Closed
- March 31, 2025 (publisher's date)
- Publisher flags
- Legislative
- Publisher topics
- Departmental Operational Issues, Food; Drug and Device Safety, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
1 more, of which 0 are open in the publisher's file.
- FDA should ensure that assessment reviews are timely.HHS OIG 13-E-04-029.07 · issued Feb 12, 2013 · closed Mar 31, 2025Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.